Semi-Annual Consolidated Statement Of Income

Cyfuse Biomedical K.K. - Filing #7372948

Concept 2023-01-01 to
2023-09-30
2022-01-01 to
2022-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
29,729,000 JPY
340,755,000 JPY
Cost of sales
17,653,000 JPY
124,016,000 JPY
Ordinary profit (loss)
-532,243,000 JPY
-232,579,000 JPY
Gross profit (loss)
12,076,000 JPY
216,739,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
540,281,000 JPY
465,924,000 JPY
Extraordinary losses
JPY
38,325,000 JPY
Profit (loss) before income taxes
-532,243,000 JPY
-270,904,000 JPY
Operating profit (loss)
-528,204,000 JPY
-249,185,000 JPY
Non-operating income
Interest income
33,000 JPY
33,000 JPY
Non-operating income
11,427,000 JPY
30,260,000 JPY
Income taxes - current
2,338,000 JPY
1,506,000 JPY
Non-operating expenses
Interest expenses
7,370,000 JPY
4,942,000 JPY
Non-operating expenses
15,466,000 JPY
13,654,000 JPY
Income taxes
2,338,000 JPY
1,506,000 JPY
Profit (loss)
-534,582,000 JPY
-272,411,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.